Although our current work highlights the potential role of FAO induction by PPARα in ameliorating obesity‐driven chemoresistance, it does not preclude the involvement of other PPARα‐dependent pathways. The gene discussed is PPARA; the disease is obesity due to melanocortin 4 receptor deficiency.